Metabolic Case Study Case
docx
keyboard_arrow_up
School
East Tennessee State University *
*We aren’t endorsed by this school
Course
5014
Subject
Health Science
Date
Dec 6, 2023
Type
docx
Pages
5
Uploaded by DoctorGazelle3328
Running Head: Metabolic Case Study
Metabolic Case Study Case
Roxy Shortridge
East Tennessee State University
NRSE 5014 – 915
Dr. Kim Hudson-Gallogly
September 20, 2023
Running Head: Metabolic Case Study
1.)
Based on the above information, what is the most likely cause of this patient’s symptoms?
What were the most pertinent findings that led you to this diagnosis? (Please explain)
a.
A 10-year-old male is seen for a routine sports physical. The patient reports no
changes in health from his previous physical which was completed one year ago. He
does not currently take any prescription or over-the-counter medications. His mother
reports a well-balanced diet, and that the patient has been physically active this
summer playing football. After reviewing the lab results the patient altered his diet
by not eating fast food, soda, or processed food. The mother now reports that the
patient has increased his water consumption and urination. He also collapsed from
abdominal pain a few days ago. Based off the patient’s history, signs and symptoms,
and laboratory results the patient most likely has type 1 diabetes (T1D). The patient
has had increased thirst and urination, weight loss, stomach pain. The patient had
elevated blood glucose levels, glucose, ketones, and protein in his urine. All these
signs and laboratory values correlate with a diagnosis of diabetes. “It is essential that
diabetes self-management education and support, medical nutrition therapy, and
psychosocial support be provided at diagnosis and regularly thereafter in a
developmentally appropriate format that builds on prior knowledge by individuals
experienced with the biological, educational, nutritional, behavioral, and emotional
needs of the growing child and family.” (American Diabetes Association, 2020).
Based off of the sudden onset of symptoms, laboratory values reported, and the
patient’s age, type 1 diabetes would be the diagnosis I would make as the healthcare
provider.
Running Head: Metabolic Case Study
2.)
Describe the pathophysiology and epidemiology of your diagnosis above? What age group is
most likely to receive this diagnosis (describe the prevalence of this disease within this
specific age group)?
a.
“Among the autoimmune diseases, the most common serious disease is the type 1
diabetes (T1D).” (Dariya, et al., 2019). The pathophysiology behind type 1 diabetes
is a result of the body’s immune system attacking the beta cells of the islets of
Langerhans in the pancreas. This leads to insulin secretion decreasing until the body
can no longer maintain normal blood glucose levels. The age group that is most
commonly diagnosed with this condition is children and adolescents under the age of
20 years old. “283,000 children and adolescents younger than age 20 years—or 35
per 10,000 US youths—had diagnosed diabetes. This includes 244,000 with type 1
diabetes.” (CDC, 2022). Type I diabetes was known as ‘juvenile’ diabetes for many
years as children are primarily diagnosed with this condition.
3.)
Who would you refer this patient to (what specialty)? What type of medication management
should this patient expect (long term)? What education should this patient/family receive?
a.
As the healthcare provider I would refer this patient to an endocrinologist to
primarily manage their diabetes. I would also refer the patient to a nutritionist who
can educate the patient and family on diet and exercise including carbohydrate
counting. I would collaborate with a dentist, eye doctor, foot doctor and pharmacist
to ensure that the patient is receiving the care and education that is needed to control
their blood glucose levels. I would expect this patient to be managed using oral
medication, and possibly insulin if needed. The patient and family would need to be
educated on the signs and symptoms of hypoglycemia such as excessive sweating,
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
Running Head: Metabolic Case Study
lightheadedness, increased heart rate, blurred vision, confusion, and weakness. It is
important to also know the signs and symptoms of hyperglycemia such as excessive
thirst, headache, fruity breath, and fatigue. It is important to also educate and discuss
diet modifications that are needed to maintain proper glucose control. “Frequent
blood glucose monitoring is a cornerstone of intensive diabetes management and is
associated with lower hemoglobin A1c values and decreases the occurrence of both
hypo- and hyperglycemia.” (Marks & Wolfsdorf, 2020). Educating the patient and
family on proper medication administration and how to obtain a blood glucose level
is imperative when caring for a patient with type I diabetes.
4.)
What are the long-term risks if this diagnosis is not properly managed?
a.
A complication that can occur from diabetes can be diabetic ketoacidosis. “Diabetic
ketoacidosis (DKA) is a serious complication of diabetes that can be life-threatening.
DKA develops when you don’t have enough insulin to let blood sugar into your
cells.” (CDC, 2023). There are several long-term risks of not properly managing
diabetes mellitus type I. These can include blindness, stroke, heart and blood vessel
disease, kidney failure, amputations, wound complications, and nerve damage.
Running Head: Metabolic Case Study
References
American Diabetes Association. (2020, December 4).
13. children and adolescents: Standards of
medical care in diabetes-2021
.
https://diabetesjournals.org/care/article/44/Supplement_1/S180/30606/13-Children-and-
Adolescents-Standards-of-Medical
CDC. (2022, September 30).
Prevalence of diagnosed diabetes
. Centers for Disease Control and
Prevention.
https://www.cdc.gov/diabetes/data/statistics-report/diagnosed-diabetes.html
CDC. (2023, September 5).
What is type 1 diabetes?
. Centers for Disease Control and
Prevention. https://www.cdc.gov/diabetes/basics/what-is-type-1-diabetes.html
Dariya, B., Chalikonda, G., Srivani, G., Alam, A., & Nagaraju, G. P. (2019).
Pathophysiology,
etiology, epidemiology of type 1 diabetes and computational approaches for immune
targets and therapy
. Critical ReviewsTM in Immunology.
https://www.dl.begellhouse.com/journals/2ff21abf44b19838,73650a9a449aa3f2,440b2529
5ae82d86.html?
utm_source=TrendMD&utm_medium=cpc&utm_campaign=Crit_Rev_Immunol_TrendM
D_1
Marks, B. E., & Wolfsdorf, J. I. (2020, February 26).
Monitoring of Pediatric Type 1 diabetes
.
Frontiers. https://www.frontiersin.org/articles/10.3389/fendo.2020.00128/full